CIK 0001802768
- Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 212-883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,573,345
- in 6 filings, $32.6M under 10b5-1 plans
Net −$32,573,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-24 | Legorreta Pablo G. CEO, Chairman of the Board | Purchase | +150,000 | $32.25 | $4.8M | 380,000 |
| 2023-05-22 | RIGGS RORY B Director | Sale | −1,750,000 | $32.82 | $57.4M | 6,762 |
| 2023-05-17 | Legorreta Pablo G. CEO, Chairman of the Board | Purchase | +69,612 | $32.94 | $2.3M | 230,000 |
| 2023-05-16 | Legorreta Pablo G. CEO, Chairman of the Board | Purchase | +160,388 | $33.57 | $5.4M | 160,388 |
| 2023-05-12 | Legorreta Pablo G. CEO, Chairman of the Board | Gift · ICAI Interests | −10,269 | 0 | ||
| 2023-05-12 | Legorreta Pablo G. CEO, Chairman of the Board | Gift · ICAI Interests | +10,269 | 692,701 | ||
| 2023-05-09 | RIGGS RORY B Director | Conversion | +300,000 | 1,756,762 | ||
| 2023-05-09 | RIGGS RORY B Director | Conversion · LP interests in RPI US Partners 2019, LP | −30,000 | 354,059 | ||
| 2023-03-31 | Fernandez Henry A Director | Grant or award | +1,049 | $35.73 | $37K | 29,036 |
| 2023-03-31 | Bassler Bonnie L Director | Grant or award | +1,049 | $35.73 | $37K | 34,830 |
| 2023-03-30 | RIGGS RORY B Director | Sale | −130,024 | $36.26 | $4.7M | 1,456,762 |
| 2023-03-29 | RIGGS RORY B Director | Sale | −9,926 | $36.95 | $367K | 1,586,786 |
| 2023-03-29 | Lloyd George W. EVP, Investments & CLO | Sale | −12,779 | $37.03 | $473K | 212,221 |
| 2023-03-28 | Lloyd George W. EVP, Investments & CLO | Sale | −100,000 | $37.06 | $3.7M | 225,000 |
| 2023-02-23 | Lloyd George W. EVP, Investments & CLO | Sale | −25,000 | $37.27 | $932K | 325,000 |
| 2023-02-22 | Urist Marshall EVP, Research & Investments | Sale | −23,333 | $37.30 | $870K | 46,667 |
| 2023-02-17 | RIGGS RORY B Director | Conversion | +1,500,000 | 1,596,712 | ||
| 2023-02-17 | RIGGS RORY B Director | Conversion · LP interests in RPI US Partners 2019, LP | −150,000 | 384,059 | ||
| 2023-02-17 | Urist Marshall EVP, Research & Investments | Conversion | +70,000 | 70,000 | ||
| 2023-02-17 | Urist Marshall EVP, Research & Investments | Conversion · LP interests in RPI US Partners 2019, LP | −7,000 | 128,594 |
Page 13 of 16 · 315 trades